Skip to main navigation Skip to search Skip to main content

I-Corps: Multiplexed paper-based test for rapid diagnosis of early-stage Lyme Disease

Project: Research

Abstract & Details

Description

Award ID: 2055749

The broader impact/commercialization potential of this I-Corps project is the development of a low-cost rapid diagnostic tool with the ability to measure multiple health markers in a single test. Development of this platform may benefit the healthcare system by improving the accessibility of diagnostic and prognostic testing that requires a panel of measurements. Specifically, there is potential for an early-stage Lyme disease (LD) diagnostic. Approximately 300,000 people contract LD each year, incurring a $1.3 billion cost to the medical system. Unfortunately, much of the societal and economic costs of LD stem from misdiagnosis due to the low sensitivity of the current Centers for Disease Control (CDC)-recommended testing protocol, which is typically
NSF Program Director: Ruth Shuman
StatusClosed
Effective start/end date03/01/2103/31/22

Funding

  • I-Corps Teams: $50,000.00

Active Fiscal Year

  • FY2022

Start Fiscal Year

  • FY2021

TIP Programs

  • I-Corps Teams

Key Technology Areas

  • Biotechnology
  • (confidence score: 100%)

Technology Foci

  • Synthetic Biology
  • (confidence score: 99%)
  • Medical Technology
  • (confidence score: 99%)

Congressional District at Award

  • District n. 36 of California

Current Congressional District

  • District n. 36 of California

United States

  • California

Core Based Statistical Area (CBSA)

  • Los Angeles-Long Beach-Anaheim, CA

County

  • County: Los Angeles, CA

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint. Learn more about Elsevier's Fingerprint Engine here: https://beta.elsevier.com/products/elsevier-fingerprint-engine